SE0302665D0 - Novel Process - Google Patents

Novel Process

Info

Publication number
SE0302665D0
SE0302665D0 SE0302665A SE0302665A SE0302665D0 SE 0302665 D0 SE0302665 D0 SE 0302665D0 SE 0302665 A SE0302665 A SE 0302665A SE 0302665 A SE0302665 A SE 0302665A SE 0302665 D0 SE0302665 D0 SE 0302665D0
Authority
SE
Sweden
Prior art keywords
novel process
processing
remove
drug delivery
respiratory tract
Prior art date
Application number
SE0302665A
Other languages
English (en)
Swedish (sv)
Inventor
Magnus Olsson
Eva Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302665A priority Critical patent/SE0302665D0/xx
Publication of SE0302665D0 publication Critical patent/SE0302665D0/xx
Priority to US10/574,873 priority patent/US7896005B2/en
Priority to KR1020067006753A priority patent/KR101110444B1/ko
Priority to EP04768742A priority patent/EP1680163A1/en
Priority to CN2004800363813A priority patent/CN1889991B/zh
Priority to PCT/GB2004/004202 priority patent/WO2005035036A1/en
Priority to JP2006530586A priority patent/JP4589928B2/ja
Priority to CA2541374A priority patent/CA2541374C/en
Priority to AU2004280109A priority patent/AU2004280109B2/en
Priority to MXPA06003872A priority patent/MXPA06003872A/es
Priority to CN201010221562A priority patent/CN101856532A/zh
Priority to BRPI0415189-5A priority patent/BRPI0415189A/pt
Priority to NZ546405A priority patent/NZ546405A/en
Priority to IL174735A priority patent/IL174735A/en
Priority to ZA200602831A priority patent/ZA200602831B/en
Priority to NO20062065A priority patent/NO336190B1/no
Priority to US12/876,493 priority patent/US8205611B2/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C71/00—After-treatment of articles without altering their shape; Apparatus therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0233—Conductive materials, e.g. antistatic coatings for spark prevention
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C2791/00—Shaping characteristics in general
    • B29C2791/004—Shaping under special conditions
    • B29C2791/006—Using vacuum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
SE0302665A 2003-10-07 2003-10-07 Novel Process SE0302665D0 (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE0302665A SE0302665D0 (sv) 2003-10-07 2003-10-07 Novel Process
NZ546405A NZ546405A (en) 2003-10-07 2004-10-04 Dry powder inhaler
JP2006530586A JP4589928B2 (ja) 2003-10-07 2004-10-04 乾燥粉末吸入器
AU2004280109A AU2004280109B2 (en) 2003-10-07 2004-10-04 Dry powder inhaler
EP04768742A EP1680163A1 (en) 2003-10-07 2004-10-04 Dry powder inhaler
CN2004800363813A CN1889991B (zh) 2003-10-07 2004-10-04 干粉吸入器
PCT/GB2004/004202 WO2005035036A1 (en) 2003-10-07 2004-10-04 Dry powder inhaler
US10/574,873 US7896005B2 (en) 2003-10-07 2004-10-04 Dry powder inhaler
CA2541374A CA2541374C (en) 2003-10-07 2004-10-04 Dry powder inhaler
KR1020067006753A KR101110444B1 (ko) 2003-10-07 2004-10-04 건조 분말 흡입기
MXPA06003872A MXPA06003872A (es) 2003-10-07 2004-10-04 Inhalador de polvo seco.
CN201010221562A CN101856532A (zh) 2003-10-07 2004-10-04 干粉吸入器
BRPI0415189-5A BRPI0415189A (pt) 2003-10-07 2004-10-04 inalador de pó seco
IL174735A IL174735A (en) 2003-10-07 2006-04-03 Dry powder inhaler
ZA200602831A ZA200602831B (en) 2003-10-07 2006-04-06 Dry powder inhaler
NO20062065A NO336190B1 (no) 2003-10-07 2006-05-08 Tørrpulver-inhalator
US12/876,493 US8205611B2 (en) 2003-10-07 2010-09-07 Dry powder inhaler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302665A SE0302665D0 (sv) 2003-10-07 2003-10-07 Novel Process

Publications (1)

Publication Number Publication Date
SE0302665D0 true SE0302665D0 (sv) 2003-10-07

Family

ID=29398687

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302665A SE0302665D0 (sv) 2003-10-07 2003-10-07 Novel Process

Country Status (15)

Country Link
US (2) US7896005B2 (https=)
EP (1) EP1680163A1 (https=)
JP (1) JP4589928B2 (https=)
KR (1) KR101110444B1 (https=)
CN (2) CN101856532A (https=)
AU (1) AU2004280109B2 (https=)
BR (1) BRPI0415189A (https=)
CA (1) CA2541374C (https=)
IL (1) IL174735A (https=)
MX (1) MXPA06003872A (https=)
NO (1) NO336190B1 (https=)
NZ (1) NZ546405A (https=)
SE (1) SE0302665D0 (https=)
WO (1) WO2005035036A1 (https=)
ZA (1) ZA200602831B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1015883A3 (fr) * 2004-06-08 2005-10-04 Occhio Procede et dispositif de dispersion de poudres seches.
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2346509B1 (en) 2008-10-07 2020-05-13 Horizon Orphan LLC Inhalation of levofloxacin for reducing lung inflammation
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
GB0912373D0 (en) 2009-07-16 2009-08-26 Innovata Biomed Ltd Improvements in or relating to dry powder inhalers
RU2563809C2 (ru) 2009-09-04 2015-09-20 Мпекс Фармасьютикалс, Инк. Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
GB201118188D0 (en) * 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
US11052202B2 (en) * 2012-11-07 2021-07-06 Chiesi Farmaceutici S.P.A. Drug delivery device for the treatment of patients with respiratory diseases
PL3789066T3 (pl) * 2014-03-03 2023-03-20 Adherium (Nz) Limited Monitor prawidłowości podawania leku do urządzenia dostarczającego suchy sproszkowany lek
NO2709641T3 (https=) 2014-03-10 2018-05-12
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
RU2018145364A (ru) 2016-06-27 2020-07-28 Ачиллион Фармасьютикалс, Инк. Хиназолиновые и индольные соединения для лечения медицинских нарушений
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
CN108771761B (zh) * 2018-08-16 2021-12-14 上海方予健康医药科技有限公司 一种糖皮质激素与β2受体激动剂的复方干粉吸入剂的制备工艺
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
EP3866773B1 (en) 2018-10-16 2024-08-28 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
CN119837855A (zh) 2019-12-19 2025-04-18 乔治亚州大学研究基金会 用于治疗细菌感染和增强抗生素的化合物
WO2021168320A1 (en) 2020-02-20 2021-08-26 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
USD949321S1 (en) * 2020-05-29 2022-04-19 NuvoAir AB Housing for an add-on sensor for an inhaler
WO2022066774A1 (en) 2020-09-23 2022-03-31 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement mediated disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3274065D1 (de) * 1981-07-08 1986-12-11 Draco Ab Powder inhalator
SE9400257D0 (sv) * 1994-01-27 1994-01-27 Astra Ab Spacer
SE9400570D0 (sv) 1994-02-21 1994-02-21 Astra Ab Inhalation device, inhaler and processing unit
US6390291B1 (en) * 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6119853A (en) * 1998-12-18 2000-09-19 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
US6315112B1 (en) * 1998-12-18 2001-11-13 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
GB2353222B (en) 1999-06-23 2001-09-19 Cambridge Consultants Inhalers
GB0107106D0 (en) 2001-03-21 2001-05-09 Boehringer Ingelheim Pharma Powder inhaler formulations
WO2003035028A1 (en) 2001-10-19 2003-05-01 Nektar Therapeutics Modulating charge density to produce improvements in the characteristics of spray-dried proteins
GB0130857D0 (en) * 2001-12-22 2002-02-06 Glaxo Group Ltd Medicament dispenser

Also Published As

Publication number Publication date
US8205611B2 (en) 2012-06-26
IL174735A (en) 2010-12-30
KR20060115728A (ko) 2006-11-09
IL174735A0 (en) 2006-08-20
MXPA06003872A (es) 2006-07-03
CN101856532A (zh) 2010-10-13
BRPI0415189A (pt) 2006-11-28
JP2007507270A (ja) 2007-03-29
AU2004280109A1 (en) 2005-04-21
ZA200602831B (en) 2007-07-25
EP1680163A1 (en) 2006-07-19
KR101110444B1 (ko) 2012-02-17
US20110056089A1 (en) 2011-03-10
JP4589928B2 (ja) 2010-12-01
CA2541374A1 (en) 2005-04-21
US7896005B2 (en) 2011-03-01
WO2005035036A1 (en) 2005-04-21
NZ546405A (en) 2008-11-28
NO336190B1 (no) 2015-06-08
US20070107721A1 (en) 2007-05-17
CN1889991B (zh) 2010-09-08
AU2004280109B2 (en) 2008-05-22
NO20062065L (no) 2006-06-29
CA2541374C (en) 2013-05-14
CN1889991A (zh) 2007-01-03

Similar Documents

Publication Publication Date Title
SE0302665D0 (sv) Novel Process
PL371736A1 (en) Method for administering glp-1 molecules
UA99431C2 (uk) Спосіб збирання пристрою для доставки ліків та пристрій для доставки ліків
AU2003239433A1 (en) Delivery of drug amines through an inhalation route
MY161079A (en) Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
TNSN08284A1 (en) Masking the taste of powders
EP2708256A3 (en) Device and method for delivery of a medicament
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
GB0217294D0 (en) Medicaments
MX2008010172A (es) Suministro pulmonar de inhibidor de proteinasa alafa-i.
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
SE0303571D0 (sv) Medical product for moisture-sensitive medicaments
NZ628513A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
GB2400565B (en) Nasal drug delivery
WO2007098106A3 (en) Respiratory tract delivery of interferon-tau
FI20020909A0 (fi) Inhalaattori, inhalaattorin komponentti ja menetelmä sellaisen valmistamiseksi
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
ITBO20020310A1 (it) Apparato di controllo dell ' erogazione di gas medicinali , particolarmente per l ' ausilio alla respirazione
WO2004080477A8 (en) Aplidine for multiple myeloma treatment
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
DE50115277D1 (de) Arzneimittelkompositionen aus tiotropiumsalzen und
NO20054034L (no) Fremgangsmate for behandling av hypotyroidisme.
AU2003246840A8 (en) Anti-hiv composition, production method thereof and medicament
TW200626167A (en) Sophorae Radix extract for prevention and treatment of respiratory diseases